Literature DB >> 10375350

Venlafaxine-associated hepatitis.

Y Horsmans, M De Clercq, C Sempoux.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10375350     DOI： 10.7326/0003-4819-130-11-199906010-00014

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  7 in total

Review 1.  The use of psychotropics in the medically ill.

Authors:  M J Robinson; J L Levenson
Journal:  Curr Psychiatry Rep       Date:  2000-06       Impact factor: 5.285

2.  Polypharmacy, multiple natural health products and hepatotoxicity.

Authors:  Kosta Cvijovic; Heather Boon; Walter Jaeger; Sunita Vohra
Journal:  CMAJ       Date:  2011-07-04       Impact factor: 8.262

3.  Adverse hepatic reactions associated with calcium carbimide and disulfiram therapy: is there still a role for these drugs?

Authors:  Carmen Verge; M Isabel Lucena; Enrique López-Torres; M José Puche-Garcia; Enrique Fraga; Manuel Romero-Gomez; Raúl J Andrade
Journal:  World J Gastroenterol       Date:  2006-08-21       Impact factor: 5.742

Review 4.  Treatment of anxiety and depression in transplant patients: pharmacokinetic considerations.

Authors:  Catherine C Crone; Geoffrey M Gabriel
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

Review 5.  Pharmacokinetic changes of psychotropic drugs in patients with liver disease: implications for dose adaptation.

Authors:  Chantal Schlatter; Sabin S Egger; Lydia Tchambaz; Stephan Krähenbühl
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 6.  Psychotropic drugs and liver disease: A critical review of pharmacokinetics and liver toxicity.

Authors:  Diogo Telles-Correia; António Barbosa; Helena Cortez-Pinto; Carlos Campos; Nuno B F Rocha; Sérgio Machado
Journal:  World J Gastrointest Pharmacol Ther       Date:  2017-02-06

7.  Early intervention of acute liver injury related to venlafaxine: A case report.

Authors:  Lin Fang; Shushan Wang; Leiming Cao; Kun Yao
Journal:  Medicine (Baltimore)       Date:  2021-12-10       Impact factor: 1.817
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.